drugset / Trial / NCT06619665

A Study of MK-6552 in Sleep Deprived Healthy Participants (MK-6552-003)

NCT06619665

Phase 1 Completed 18 enrolled Merck Sharp & Dohme LLC
RandomizedCrossoverDouble-blindBasic science

Summary

This study examined the safety of the drug MK-6552 and if people tolerated it. It also studied whether MK-6552 works better than placebo for staying awake in sleep deprived healthy participants.

Timeline

Start
2024-03-19
Primary completion
2024-07-16
Completion
2024-07-16

Drugs

EvaluationDrugModalityDoseRoute
Subject MK-6552 Unknown Oral
Subject Modafinil Small molecule Oral

Indications